Muscarinic Acetylcholine Receptors Inhibit Fyn Activity in the Rat Striatum In Vivo

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Src family kinases (SFKs), including Src and Fyn, are crucial for neuronal and synaptic functions in the striatum.
• Dysregulation of SFKs is implicated in neuropsychiatric and neurodegenerative disorders.
• Muscarinic acetylcholine (mACh) receptors are abundant in striatal neurons and regulate striatal function.

Purpose of the Study:

• To investigate the role of mACh receptors in regulating SFKs within the adult rat striatum in vivo.
• To determine if mACh receptor activity influences SFK phosphorylation and kinase activity.

Main Methods:

• Systemic administration of mACh receptor antagonists (scopolamine, atropine) in adult male and female rats.
• Measurement of SFK phosphorylation levels in different striatal subdivisions (caudate putamen, nucleus accumbens).
• Immunoprecipitation and kinase assays to assess Fyn and Src phosphorylation and activity.

Main Results:

• Pharmacological blockade of mACh receptors significantly increased SFK phosphorylation in the striatum, in a time-dependent and reversible manner.
• Scopolamine selectively enhanced the phosphorylation and kinase activity of Fyn, but not Src.
• Coadministration of scopolamine with a dopamine D1 receptor agonist further boosted striatal SFK phosphorylation.

Conclusions:

• mACh receptors play a significant role in regulating SFKs, predominantly Fyn, in striatal neurons.
• Endogenous mACh receptor signaling normally exerts an inhibitory effect on Fyn activity in the striatum.
• Findings suggest a novel regulatory pathway involving mACh receptors and SFKs in striatal function and potential disease pathogenesis.